{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:29:05Z","timestamp":1793647745434,"version":"4.5.1"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,16]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Chronic hepatitis C (CHC), including cirrhosis, remains a major global health challenge. While direct-acting antivirals have improved prognoses, barriers to diagnosis and equitable access hinder World Health Organization\u2019s 2030 eradication target. This study systematically assessed the global burden and trends to inform prevention strategies. Based on the Global Burden of Disease Study 2021 database, this analysis quantified the absolute numbers and age-standardized rates (ASRs) of 4 disease burden indicators, including incidence, prevalence, deaths, and disability-adjusted life years (DALYs), for CHC, including cirrhosis, across global, regional, and national levels from 1990 to 2021. Temporal trends were quantified using the estimated annual percent change and Joinpoint regression. Decomposition, health inequality, and frontier analyses were used to characterize drivers and socioeconomic gradients, with Bayesian age-period-cohort projections to 2036. Analyses were stratified by socio-demographic index (SDI), sex, and age. In 2021, the global numbers of incidence, prevalence, deaths, and DALYs for CHC, including cirrhosis, were substantially higher than in 1990, though the ASRs declined. Significant socioeconomic inequalities persisted, with the highest burden in low SDI regions. South Asia, Southeast Asia, East Asia, Western Sub-Saharan Africa, and North Africa and the Middle East showed the highest absolute numbers for disease burden indicators; Sub-Saharan Africa, Central Asia, Southeast Asia, and North Africa and the Middle East had the highest ASRs. Males exhibited higher deaths and DALYs than females. Decomposition analysis identified population growth and aging as drivers of increased disease burden, partially countered by epidemiological improvements. Frontier analysis revealed substantial unrealized potential in low SDI settings. Projections indicated a continued decline in ASRs, but the number of prevalence may reach approximately 150 million by 2036 under the continuation of current trends. Despite declining ASRs of CHC, including cirrhosis, from 1990 to 2021, the absolute burden increased due to demographic shifts. Pronounced socioeconomic inequalities persist, with the highest burden concentrated in low SDI regions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000051118","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:01:21Z","timestamp":1792173681000},"page":"e51118","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Global, regional, and national burden of chronic hepatitis C including cirrhosis from 1990 to 2021, alongside projections for the next 15 years"],"prefix":"10.1097","volume":"105","author":[{"given":"Shicheng","family":"Gu","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaojian","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyu","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Geriatric, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjun","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1926-7330","authenticated-orcid":false,"given":"Mingqi","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20261102","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cld.2005.05.003","article-title":"Natural history of hepatitis C.","volume":"9","author":"Thomas","year":"2005","journal-title":"Clin Liver Dis"},{"key":"R3-20261102","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1440-1746.2002.02730.x","article-title":"Is severe liver disease a common outcome for people with chronic hepatitis C?","volume":"17","author":"Dore","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"R4-20261102","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.3748\/wjg.v26.i22.2931","article-title":"Liver-related effects of chronic hepatitis C antiviral treatment.","volume":"26","author":"Laursen","year":"2020","journal-title":"World J Gastroenterol"},{"key":"R5-20261102","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1053\/j.gastro.2018.10.024","article-title":"Status of direct-acting antiviral therapy for hepatitis C virus infection and remaining challenges.","volume":"156","author":"Baumert","year":"2019","journal-title":"Gastroenterology"},{"key":"R6-20261102","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S2468-1253(22)00386-7","article-title":"Global reporting of progress towards elimination of hepatitis B and hepatitis C.","volume":"8","author":"Cui","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R7-20261102","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.","volume":"2","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R10-20261102","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R11-20261102","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R12-20261102","first-page":"5","article-title":"The concept of socio-demographic index (SDI) and its application.","volume":"31","author":"Yu","year":"2020","journal-title":"J Public Health Prevent Med"},{"key":"R14-20261102","doi-asserted-by":"crossref","first-page":"1545085","DOI":"10.3389\/fnut.2025.1545085","article-title":"Low dietary calcium intake leads to a higher colorectal cancer burden in countries with low social development: findings from the Global Burden of Disease Study 2021.","volume":"12","author":"Wu","year":"2025","journal-title":"Front Nutr"},{"key":"R15-20261102","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/jssam\/smac014","article-title":"Joinpoint regression methods of aggregate outcomes for complex survey data.","volume":"11","author":"Liu","year":"2023","journal-title":"J Survey Stat Methodol"},{"key":"R16-20261102","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1353\/dem.0.0060","article-title":"Revisiting Das Gupta: refinement and extension of standardization and decomposition.","volume":"46","author":"Chevan","year":"2009","journal-title":"Demography"},{"key":"R17-20261102","doi-asserted-by":"crossref","first-page":"e0216613","DOI":"10.1371\/journal.pone.0216613","article-title":"A new method to attribute differences in total deaths between groups to population size, age structure and age-specific mortality rate.","volume":"14","author":"Cheng","year":"2019","journal-title":"PLoS One"},{"key":"R18-20261102","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.kint.2018.04.011","article-title":"Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016.","volume":"94","author":"Xie","year":"2018","journal-title":"Kidney Int"},{"key":"R19-20261102","doi-asserted-by":"crossref","first-page":"29034","DOI":"10.3402\/gha.v8.29034","article-title":"Promoting health equity: WHO health inequality monitoring at global and national levels.","volume":"8","author":"Hosseinpoor","year":"2015","journal-title":"Glob Health Action"},{"key":"R20-20261102","doi-asserted-by":"crossref","first-page":"e1388","DOI":"10.1016\/S2214-109X(19)30360-2","article-title":"Rheumatic heart disease burden, trends, and inequalities in the Americas, 1990\u20132017: a population-based study.","volume":"7","author":"Ordunez","year":"2019","journal-title":"Lancet Glob Health"},{"key":"R21-20261102","doi-asserted-by":"crossref","first-page":"31787","DOI":"10.1038\/s41598-024-82897-4","article-title":"Global burden and trends of testicular cancer in adolescents and young adults from 1990 to 2021, with predictions to 2035.","volume":"14","author":"Yu","year":"2024","journal-title":"Sci Rep"},{"key":"R22-20261102","doi-asserted-by":"crossref","first-page":"e0147663","DOI":"10.1371\/journal.pone.0147663","article-title":"Assessing progress towards public health, human rights, and international development goals using frontier analysis.","volume":"11","author":"Luh","year":"2016","journal-title":"PLoS One"},{"key":"R23-20261102","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/bimj.201500263","article-title":"Projecting the future burden of cancer: Bayesian age-period-cohort analysis with integrated nested Laplace approximations.","volume":"59","author":"Riebler","year":"2017","journal-title":"Biom J"},{"key":"R24-20261102","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/sim.3858","article-title":"Bayesian bivariate meta-analysis of diagnostic test studies using integrated nested Laplace approximations.","volume":"29","author":"Paul","year":"2010","journal-title":"Stat Med"},{"key":"R25-20261102","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","article-title":"Guidelines for accurate and transparent health estimates reporting: the GATHER statement.","volume":"388","author":"Stevens","year":"2016","journal-title":"Lancet"},{"key":"R27-20261102","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0140-6736(16)30579-7","article-title":"The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013.","volume":"388","author":"Stanaway","year":"2016","journal-title":"Lancet"},{"key":"R28-20261102","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"R29-20261102","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S2468-1253(18)30270-X","article-title":"Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission.","volume":"4","author":"Cooke","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R30-20261102","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/liv.14282","article-title":"Securing sustainable funding for viral hepatitis elimination plans.","volume":"40","author":"Hatzakis","year":"2020","journal-title":"Liver Int"},{"key":"R31-20261102","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s12072-012-9417-9","article-title":"Population-attributable estimates for risk factors associated with hepatitis B and C: policy implications for Pakistan and other South Asian countries.","volume":"7","author":"Ahmed","year":"2013","journal-title":"Hepatol Int"},{"key":"R32-20261102","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1186\/1471-2458-11-779","article-title":"A comprehensive situation assessment of injection practices in primary health care hospitals in Bangladesh.","volume":"11","author":"Chowdhury","year":"2011","journal-title":"BMC Public Health"},{"key":"R33-20261102","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S2468-1253(16)30031-0","article-title":"Hepatitis B and hepatitis C in southeast and southern Asia: challenges for governments.","volume":"1","author":"Wait","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R34-20261102","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jceh.2014.05.006","article-title":"Consensus statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: status report of HCV infection in India.","volume":"4","author":"Puri","year":"2014","journal-title":"J Clin Exp Hepatol"},{"key":"R35-20261102","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/jgh.15827","article-title":"Seroprevalence and burden of hepatitis C virus infection in WHO South-East Asia Region: a systematic review.","volume":"37","author":"Goel","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"key":"R36-20261102","first-page":"962","article-title":"Guidelines for the prevention and treatment of hepatitis C (2019 version).","volume":"27","year":"2019","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"R37-20261102","doi-asserted-by":"crossref","first-page":"ofz040","DOI":"10.1093\/ofid\/ofz040","article-title":"Prevalence of anti-HCV antibody among the general population in Mainland China between 1991 and 2015: a systematic review and meta-analysis.","volume":"6","author":"Gao","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"R38-20261102","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1572-0241.2008.01789.x","article-title":"High prevalence of hepatitis C virus infection among immigrants from the former Soviet Union in the New York City metropolitan area: results of a community-based screening program.","volume":"103","author":"Batash","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"R39-20261102","doi-asserted-by":"crossref","first-page":"e015972","DOI":"10.1136\/bmjgh-2024-015972","article-title":"Projected health workforce requirements and shortage for addressing the disease burden in the WHO Africa Region, 2022\u20132030: a needs-based modelling study.","volume":"7","author":"Asamani","year":"2024","journal-title":"BMJ Glob Health"},{"key":"R40-20261102","doi-asserted-by":"crossref","first-page":"w849","DOI":"10.1377\/hlthaff.28.5.w849","article-title":"Estimates of health care professional shortages in sub-Saharan Africa by 2015.","volume":"28","author":"Scheffler","year":"2009","journal-title":"Health Aff (Millwood)"},{"key":"R41-20261102","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2334-2-29","article-title":"Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt.","volume":"2","author":"Rao","year":"2002","journal-title":"BMC Infect Dis"},{"key":"R42-20261102","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.3748\/wjg.v24.i38.4330","article-title":"Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations.","volume":"24","author":"Omran","year":"2018","journal-title":"World J Gastroenterol"},{"key":"R43-20261102","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/jvh.12668","article-title":"National treatment programme of hepatitis C in Egypt: hepatitis C virus model of care.","volume":"24","author":"El-Akel","year":"2017","journal-title":"J Viral Hepat"},{"key":"R44-20261102","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/tmi.70137","article-title":"Comparative impact of active versus passive surveillance on hepatitis C virus testing uptake, diagnosis and linkage to care in low- and middle-income countries: a systematic review and meta-analysis.","volume":"31","author":"Motau","year":"2026","journal-title":"Trop Med Int Health"},{"key":"R45-20261102","first-page":"101803","article-title":"Progressing towards global hepatitis C elimination: a systematic review and meta-analysis of care cascades in key populations.","volume":"67","author":"Zou","year":"2026","journal-title":"Lancet Reg Health West Pac"},{"key":"R46-20261102","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/j.gastro.2009.09.067","article-title":"Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression.","volume":"138","author":"Davis","year":"2010","journal-title":"Gastroenterology"},{"key":"R47-20261102","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"issue":"Suppl 1","key":"R48-20261102","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/liv.14836","article-title":"Is elimination of hepatitis C virus realistic by 2030: Eastern Europe.","volume":"41","author":"Isakov","year":"2021","journal-title":"Liver Int"},{"key":"R49-20261102","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/QCO.0000000000000326","article-title":"Syphilis, hepatitis C and HIV in Eastern Europe.","volume":"30","author":"Bailey","year":"2017","journal-title":"Curr Opin Infect Dis"},{"key":"R50-20261102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugpo.2019.07.016","article-title":"Elimination of hepatitis C virus infection among people who use drugs: ensuring equitable access to prevention, treatment, and care for all.","volume":"72","author":"Grebely","year":"2019","journal-title":"Int J Drug Policy"},{"key":"R52-20261102","first-page":"700","article-title":"Hepatitis C virus elimination in the united states: challenges, progress, and future steps.","volume":"19","author":"Nguyen","year":"2023","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"R53-20261102","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3390\/v16071115","article-title":"Prevalence and modes of transmission of hepatitis C virus infection: a historical worldwide review.","volume":"16","author":"Stroffolini","year":"2024","journal-title":"Viruses"},{"key":"R54-20261102","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0168-8278(00)00097-0","article-title":"Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.","volume":"34","author":"Poynard","year":"2001","journal-title":"J Hepatol"},{"key":"R55-20261102","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1046\/j.1365-2036.2003.01546.x","article-title":"Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: a prospective study.","volume":"17","author":"H\u00e9zode","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R56-20261102","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/j.1360-0443.2009.02696.x","article-title":"Gender and alcohol consumption: patterns from the multinational GENACIS project.","volume":"104","author":"Wilsnack","year":"2009","journal-title":"Addiction"},{"key":"R57-20261102","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00281-018-0727-4","article-title":"Sexual dimorphism in hepatitis B and C and hepatocellular carcinoma.","volume":"41","author":"Buettner","year":"2019","journal-title":"Semin Immunopathol"},{"key":"R58-20261102","doi-asserted-by":"crossref","first-page":"e44624","DOI":"10.1371\/journal.pone.0044624","article-title":"Reproductive status is associated with the severity of fibrosis in women with hepatitis C.","volume":"7","author":"Villa","year":"2012","journal-title":"PLoS One"},{"key":"R59-20261102","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1542\/peds.47.1.120","article-title":"A sex difference in immunologic responsiveness.","volume":"47","author":"Michaels","year":"1971","journal-title":"Pediatrics"},{"key":"R60-20261102","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/cid\/ciu447","article-title":"Vertical transmission of hepatitis C virus: systematic review and meta-analysis.","volume":"59","author":"Benova","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R61-20261102","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jhep.2022.05.016","article-title":"Influence of hepatitis C viral parameters on pregnancy complications and risk of mother-to-child transmission.","volume":"77","author":"Kushner","year":"2022","journal-title":"J Hepatol"},{"key":"R62-20261102","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/j.cgh.2020.09.033","article-title":"In the era of direct-acting antivirals, liver transplant delisting due to clinical improvement for hepatitis C remains infrequent.","volume":"19","author":"Bittermann","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R63-20261102","first-page":"167","article-title":"Irreversible liver failure: treatment by transplantation: part 3 of a series on liver cirrhosis.","volume":"110","author":"Pascher","year":"2013","journal-title":"Dtsch Arztebl Int"},{"key":"R64-20261102","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1186\/s12879-019-4315-6","article-title":"HCV-infected individuals have higher prevalence of comorbidity and multimorbidity: a retrospective cohort study.","volume":"19","author":"Cooper","year":"2019","journal-title":"BMC Infect Dis"},{"key":"R65-20261102","first-page":"759","article-title":"Cirrhosis: diagnosis and management.","volume":"100","author":"Smith","year":"2019","journal-title":"Am Fam Physician"},{"key":"R66-20261102","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis.","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"R67-20261102","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S2468-1253(21)00224-7","article-title":"Hepatitis C virus in sub-Saharan Africa: a long road to elimination.","volume":"6","author":"Shah","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R68-20261102","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-med-050223-111239","article-title":"Global elimination of hepatitis C virus.","volume":"76","author":"Fleurence","year":"2025","journal-title":"Annu Rev Med"},{"key":"R69-20261102","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3390\/v14061192","article-title":"Hepatitis C virus epidemiology in Lithuania: situation before introduction of the National Screening Programme.","volume":"14","author":"Ciupkeviciene","year":"2022","journal-title":"Viruses"},{"issue":"Suppl 3","key":"R70-20261102","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1093\/infdis\/jiad016","article-title":"Policy and strategy for hepatitis C virus elimination at the national level: experience in Taiwan.","volume":"228","author":"Chien","year":"2023","journal-title":"J Infect Dis"},{"key":"R71-20261102","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1016\/S2214-109X(20)30505-2","article-title":"Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis.","volume":"9","author":"Oru","year":"2021","journal-title":"Lancet Glob Health"},{"key":"R73-20261102","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41591-019-0706-x","article-title":"Global elimination of hepatitis C virus by 2030: why not?","volume":"26","author":"Dore","year":"2020","journal-title":"Nat Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000051118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:01:24Z","timestamp":1793646084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000051118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":66,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000051118","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"2025-12-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}